We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 99

Life Sciences: product regulation and liability in Sweden
  • Vinge
  • Sweden, Global
  • October 12 2017

A structured guide to product regulation and liability laws in Sweden


Navigating a complex advertising environment
  • Gorodissky & Partners
  • USA, Sweden, China, European Union
  • June 29 2016

In today’s increasingly competitive marketplace, clever advertising helps brands to stand out from the crowd. However, there is often an inevitable


One year after de-monopolisation
  • Bird & Bird
  • Sweden
  • October 21 2010

On 1 July 2009, Sweden implemented the Act on Sales of Medicinal Products, (2009:366) (ASMP) which allows entities other than the state-owned Apoteket AB to own and operate pharmacies


Changes in the pharmacy market
  • Bird & Bird
  • Sweden
  • December 31 2008

The Swedish Government sent a proposed Bill regarding changes in the pharmacy market to the Council of Legislation for comments last week


The Swedish system of generic substitution, interchangeability between reference drugs and generics
  • Bird & Bird
  • Sweden
  • August 20 2007

In order to place a generic drug on the market in Sweden, it must first be approved by the Swedish Medical Products Agency (the “SMPA”) or the European Medicines Agency, as the case may be


Intensified control over the marketing of pharmaceutical products
  • Bird & Bird
  • Sweden
  • March 9 2007

New regulations in the Medicinal Products Act (SFS: 1992:859) (the “Act”) regarding the marketing of pharmaceuticals came into force in May 2006


Sally Albertazzie
  • Steptoe & Johnson LLP